Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF

BACKGROUND: The age at which heart failure develops varies widely between countries and drug tolerance and outcomes also vary by age. We have examined the efficacy and safety of LCZ696 according to age in the Prospective comparison of angiotensin receptor neprilysin inhibitor with angiotensin conver...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhund, Pardeep S., Fu, Michael, Bayram, Edmundo, Chen, Chen-Huan, Negrusz-Kawecka, Marta, Rosenthal, Arvo, Desai, Akshay S., Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., McMurray, John J.V., Packer, Milton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595742/
https://www.ncbi.nlm.nih.gov/pubmed/26231885
http://dx.doi.org/10.1093/eurheartj/ehv330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595742/
https://www.ncbi.nlm.nih.gov/pubmed/26231885
http://dx.doi.org/10.1093/eurheartj/ehv330

Ejemplares similares